152 related articles for article (PubMed ID: 9792628)
1. Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.
Lawson JA; Li H; Rokach J; Adiyaman M; Hwang SW; Khanapure SP; FitzGerald GA
J Biol Chem; 1998 Nov; 273(45):29295-301. PubMed ID: 9792628
[TBL] [Abstract][Full Text] [Related]
2. IPF2alpha-I: an index of lipid peroxidation in humans.
Praticò D; Barry OP; Lawson JA; Adiyaman M; Hwang SW; Khanapure SP; Iuliano L; Rokach J; FitzGerald GA
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3449-54. PubMed ID: 9520386
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry.
Adiyaman M; Lawson JA; Khanapure SP; FitzGerald GA; Rokach J
Anal Biochem; 1998 Aug; 262(1):45-56. PubMed ID: 9735147
[TBL] [Abstract][Full Text] [Related]
4. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
Schwedhelm E; Tsikas D; Durand T; Gutzki FM; Guy A; Rossi JC; Frölich JC
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):99-112. PubMed ID: 10985571
[TBL] [Abstract][Full Text] [Related]
5. Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans.
Roberts LJ; Moore KP; Zackert WE; Oates JA; Morrow JD
J Biol Chem; 1996 Aug; 271(34):20617-20. PubMed ID: 8702808
[TBL] [Abstract][Full Text] [Related]
6. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography.
Tsikas D; Suchy MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():191-201. PubMed ID: 25583542
[TBL] [Abstract][Full Text] [Related]
7. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
8. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.
Reilly MP; Delanty N; Roy L; Rokach J; Callaghan PO; Crean P; Lawson JA; FitzGerald GA
Circulation; 1997 Nov; 96(10):3314-20. PubMed ID: 9396422
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways.
Kunapuli P; Lawson JA; Rokach JA; Meinkoth JL; FitzGerald GA
J Biol Chem; 1998 Aug; 273(35):22442-52. PubMed ID: 9712868
[TBL] [Abstract][Full Text] [Related]
10. Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha.
Chiabrando C; Valagussa A; Rivalta C; Durand T; Guy A; Zuccato E; Villa P; Rossi JC; Fanelli R
J Biol Chem; 1999 Jan; 274(3):1313-9. PubMed ID: 9880501
[TBL] [Abstract][Full Text] [Related]
11. Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles.
Larose J; Julien P; Bilodeau JF
J Lipid Res; 2013 May; 54(5):1505-11. PubMed ID: 23431046
[TBL] [Abstract][Full Text] [Related]
12. Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
Reilly MP; Praticò D; Delanty N; DiMinno G; Tremoli E; Rader D; Kapoor S; Rokach J; Lawson J; FitzGerald GA
Circulation; 1998 Dec 22-29; 98(25):2822-8. PubMed ID: 9860782
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS methods for the detection of isoprostanes (iPF2alpha-III and 8,12-iso-iPF2alpha-VI) as biomarkers of CCl4-induced oxidative damage to hepatic tissue.
Sicilia T; Mally A; Schauer U; Pähler A; Völkel W
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):48-55. PubMed ID: 18160027
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry.
Ohashi N; Yoshikawa M
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(1):17-24. PubMed ID: 11048736
[TBL] [Abstract][Full Text] [Related]
15. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
Schweer H; Watzer B; Seyberth HW; Nüsing RM
J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
[TBL] [Abstract][Full Text] [Related]
16. Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry.
Tsikas D; Schwedhelm E; Fauler J; Gutzki FM; Mayatepek E; Frölich JC
J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):7-17. PubMed ID: 9824213
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation.
Basu S
Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):319-25. PubMed ID: 9654406
[TBL] [Abstract][Full Text] [Related]
18. Isolation and measurement of urinary 8-iso-prostaglandin F2alpha by high-performance liquid chromatography and gas chromatography-mass spectrometry.
Ferretti A; Flanagan VP
J Chromatogr B Biomed Sci Appl; 1997 Jul; 694(2):271-6. PubMed ID: 9252040
[TBL] [Abstract][Full Text] [Related]
19. Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease.
Schwedhelm E; Böger RH
Clin Chem Lab Med; 2003 Dec; 41(12):1552-61. PubMed ID: 14708879
[TBL] [Abstract][Full Text] [Related]
20. Increased placental phospholipase A
Brien M; Larose J; Greffard K; Julien P; Bilodeau JF
Placenta; 2017 Jul; 55():54-62. PubMed ID: 28623974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
